Ireland - English - HPRA (Health Products Regulatory Authority)

xellia pharmaceuticals aps - daptomycin - powder for solution for injection/infusion - 350 milligram(s) - other antibacterials; daptomycin

Ireland - English - HPRA (Health Products Regulatory Authority)

xellia pharmaceuticals aps - daptomycin - powder for solution for injection/infusion - 500 milligram(s) - other antibacterials; daptomycin

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - daptomycin - powder for solution for injection/infusion - 350 milligram(s) - other antibacterials; daptomycin

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - daptomycin - powder for solution for injection/infusion - 500 milligram(s) - other antibacterials; daptomycin

Ireland - English - HPRA (Health Products Regulatory Authority)

noridem enterprises limited - daptomycin - powder for solution for injection/infusion - 350 milligram(s) - other antibacterials; daptomycin

Ireland - English - HPRA (Health Products Regulatory Authority)

noridem enterprises limited - daptomycin - powder for solution for injection/infusion - 500 milligram(s) - other antibacterials; daptomycin

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - daptomycin, quantity: 500 mg - injection, powder for - excipient ingredients: sodium hydroxide - daptomycin is active against gram positive bacteria only. in mixed infections where gram negative and/or certain types of anaerobic bacteria are suspected, daptomycin should be co-administered with appropriate antibacterial agent(s). consideration should be given to official guidance on the appropriate use of antibacterial agents. daptomycin is not indicated for the treatment of pneumonia.,adult patients (18 years of age and over),1. complicated skin and skin structure infections cubicin is indicated for the treatment of adults (18 years of age and over) with complicated skin and skin structure infections (csssi) who require parenteral therapy and who have intolerance to alternative agents (especially penicillin allergy) or who have failed on other therapy, and when caused by organisms known to be susceptible to daptomycin.,2. staphylococcus aureus bloodstream infections (bacteraemia) cubicin is indicated in adults (18 years of age and over) for staphylococcus aureus bloodstream infections (bacteraemia), in

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - daptomycin, quantity: 350 mg - injection, powder for - excipient ingredients: sodium hydroxide - daptomycin is active against gram positive bacteria only. in mixed infections where gram negative and/or certain types of anaerobic bacteria are suspected, daptomycin should be co-administered with appropriate antibacterial agent(s). consideration should be given to official guidance on the appropriate use of antibacterial agents. daptomycin is not indicated for the treatment of pneumonia.,adult patients (18 years of age and over) 1. complicated skin and skin structure infections cubicin is indicated for the treatment of adults (18 years of age and over) with complicated skin and skin structure infections (csssi) who require parenteral therapy and who have intolerance to alternative agents (especially penicillin allergy) or who have failed on other therapy, and when caused by organisms known to be susceptible to daptomycin.,2. staphylococcus aureus bloodstream infections (bacteraemia) cubicin is indicated in adults (18 years of age and over) for staphylococcus aureus bloodstream infections (bacteraemia), inc

Canada - English - Health Canada

sandoz canada incorporated - daptomycin - powder for solution - 500mg - daptomycin 500mg - cyclic lipopeptides

Canada - English - Health Canada

pfizer canada ulc - daptomycin - powder for solution - 350mg - daptomycin 350mg - cyclic lipopeptides